Loading...
Derniers dépôts
-
Camille Braun, Julie Mazenq, Philippe Eigenmann, Omer Kalayci, Luciana Tanno. Editorial comments on “Global assessment of the knowledge and confidence in managing allergic disorders among primary care pediatricians across Europe: An EAACI task force report”. Pediatric Allergy and Immunology, 2024, 35 (8), pp.e14210. ⟨10.1111/pai.14210⟩. ⟨hal-04946260⟩
-
Alexandre Favà, Laura Donadeu, Thomas Jouve, José Gonzalez-Costello, Laura Lladó, et al.. A comprehensive assessment of long-term SARS-CoV-2–specific adaptive immune memory in convalescent COVID-19 Solid Organ Transplant recipients. Kidney International, 2022, 101 (5), pp.1027-1038. ⟨10.1016/j.kint.2021.12.029⟩. ⟨hal-04955946⟩
-
-
Matthieu Arsicot, Raffaele Pio Ammollo, Marine Bordet, Leila Dehina-Khenniche, Olivier Thaunat, et al.. Endovascular Preparation With Innovative Custom-Made Stent-Graft Before Kidney Transplantation: The Solution for Patients With Hostile Iliac Calcification. Transplant International, 2025, 37, ⟨10.3389/ti.2024.13486⟩. ⟨hal-04955897⟩
-
-
-
S K Mahil, M Yates, S M Langan, Z Z N Yiu, T Tsakok, et al.. Risk‐mitigating behaviours in people with inflammatory skin and joint disease during the COVID‐19 pandemic differ by treatment type: a cross‐sectional patient survey*. British Journal of Dermatology, 2020, 185, pp.80 - 90. ⟨10.1111/bjd.19755⟩. ⟨hal-04953301⟩
-
Satveer K Mahil, Nick Dand, Kayleigh J Mason, Zenas Z N Yiu, Teresa Tsakok, et al.. Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study. Journal of Allergy and Clinical Immunology, 2021, 147, pp.60 - 71. ⟨10.1016/j.jaci.2020.10.007⟩. ⟨hal-04953300⟩
-
Zara Izadi, Erica J Brenner, Satveer K Mahil, Nick Dand, Zenas Z N Yiu, et al.. Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19. JAMA Network Open, 2021, 4, ⟨10.1001/jamanetworkopen.2021.29639⟩. ⟨hal-04953299⟩
-
-
Ulrich Mrowietz, Jonathan Barker, Curdin Conrad, Denis Jullien, Paolo Gisondi, et al.. Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the EMBRACE randomized trial. Journal of the European Academy of Dermatology and Venereology, 2022, 37, pp.348 - 355. ⟨10.1111/jdv.18689⟩. ⟨hal-04953295⟩
-
Jan Koren, Jo L W Lambert, Simon F Thomsen, Helen Mcateer, Gabriella Fabbrocini, et al.. Elevating the Standard of Care for Patients with Psoriasis: ‘Calls to Action’ from Epicensus, a Multistakeholder Pan-European Initiative. Dermatology and Therapy, 2022, 13, pp.245 - 268. ⟨10.1007/s13555-022-00846-3⟩. ⟨hal-04953293⟩
-
Sophia Quirke-Mcfarlane, John Weinman, Emma S Cook, Zenas Z N Yiu, Nick Dand, et al.. Nonadherence to systemic immune-modifying therapy in people with psoriasis during the COVID-19 pandemic: findings from a global cross-sectional survey. British Journal of Dermatology, 2022, 188, pp.610 - 617. ⟨10.1093/bjd/ljac144⟩. ⟨hal-04953290⟩
-
Denis Jullien, Marie-Aleth Richard, Bruno Halioua, Christel Bessette, Christian Derancourt, et al.. The Needs of Patients with Psoriasis and Benefits of Apremilast in French Clinical Practice: Results from the Observational REALIZE Study. Dermatology and Therapy, 2023, 13, pp.1361 - 1376. ⟨10.1007/s13555-023-00933-z⟩. ⟨hal-04953288⟩
-
K Schäkel, K Reich, K Asadullah, A Pinter, D Jullien, et al.. Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance (‘clinical super response’): Week 28 results from the ongoing phase IIIb randomized, double‐blind, parallel‐group, GUIDE study. Journal of the European Academy of Dermatology and Venereology, 2023, 37, pp.2016 - 2027. ⟨10.1111/jdv.19236⟩. ⟨hal-04953284⟩
-
Alexander Egeberg, Denis Jullien, Kristian Gaarn Du Jardin, Diamant Thaçi. Five-year safety of tildrakizumab in patients with moderate-to-severe psoriasis from two phase 3 trials (reSURFACE 1 and reSURFACE 2): number needed to harm for occurrence of adverse events of special interest. Journal of Dermatological Treatment, 2023, 34, ⟨10.1080/09546634.2023.2220447⟩. ⟨hal-04953283⟩
-
J R Ingram, V Bettoli, J I Espy, G Kokolakis, A Martorell, et al.. Unmet clinical needs and burden of disease in hidradenitis suppurativa: real‐world experience from EU5 and US. Journal of the European Academy of Dermatology and Venereology, 2022, 36, pp.1597 - 1605. ⟨10.1111/jdv.18163⟩. ⟨hal-04953268⟩
-
-
Sabine Blouquit-Laye, Luc Dannhoffer, Camille Braun, Anh-Tuan Dinh-Xuan, Edouard Sage, et al.. Effect of nitric oxide on epithelial ion transports in noncystic fibrosis and cystic fibrosis human proximal and distal airways. American Journal of Physiology - Lung Cellular and Molecular Physiology, 2012, 303 (7), pp.L617-L625. ⟨10.1152/ajplung.00368.2011⟩. ⟨hal-04953028⟩
-
Nombre de notices
2 263
Nombre de documents
1 650
Répartition par type de documents
Evolution
Dernières publications
-
-
Fahd Al Qureshah, Jérémie Le Pen, Nicole de Weerd, Marcela Moncada-Velez, Marie Materna, et al.. A common form of dominant human IFNAR1 deficiency impairs IFN-α and -ω but not IFN-β-dependent immunity. Journal of Experimental Medicine, 2025, 222 (2), pp.e20241413. ⟨10.1084/jem.20241413⟩. ⟨hal-04926027⟩
-
Carla Saade, Timothée Bruel, Lou-Léna Vrignaud, Martin Killian, Annabelle Drouillard, et al.. BA.1 breakthrough infection elicits distinct antibody and memory B cell responses in vaccinated-only versus hybrid immunity individuals. iScience, In press, pp.111962. ⟨10.1016/j.isci.2025.111962⟩. ⟨hal-04941427⟩
-
Adriana Traore, Kelly Charniga, Sophie Grellet, Garance Terpant, Héléna da Cruz, et al.. Monitoring SARS-CoV-2 variants with complementary surveillance systems: risk evaluation of the Omicron JN.1 variant in France, August 2023 to January 2024. Eurosurveillance, 2025, 30 (1), pp.1192-1194. ⟨10.2807/1560-7917.ES.2025.30.1.2400293⟩. ⟨hal-04895964⟩
-
Matthieu Arsicot, Raffaele Pio Ammollo, Marine Bordet, Leila Dehina-Khenniche, Olivier Thaunat, et al.. Endovascular Preparation With Innovative Custom-Made Stent-Graft Before Kidney Transplantation: The Solution for Patients With Hostile Iliac Calcification. Transplant International, 2025, 37, ⟨10.3389/ti.2024.13486⟩. ⟨hal-04955897⟩
-
-
Maria Scaturro, Alessio Lanni, Fabiola Mancini, Antonietta Girolamo, Silvia Fillo, et al.. Antimicrobial susceptibility and epidemiological types of Legionella pneumophila human isolates from Italy (1987–2020). Journal of Global Antimicrobial Resistance, 2025, 41, pp.181 - 188. ⟨10.1016/j.jgar.2024.12.030⟩. ⟨hal-04928690⟩
-
-
-